Bronchial and nonbronchial systemic artery embolization in managing haemoptysis: 31 years of experience

Cornalba, Gianpaolo; Vella, Anna Maria; Barbosa, Fabiane Silva; Greco, G; Michelozzi, Caterina; Sacrini, A.; Melchiorre, Fabio

doi:10.1007/s11547-012-0866-y

Cited by 21 publications

(13 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Major complications are rare (< 1%) and include dissection of a bronchial artery, bronchial arterial perforation by a guidewire, transient quadriplegia, transient ischaemic attack, stroke or disseminated infection [ 52 ]. Minor complications are more common (30%) and include chest pain, dysphagia and fever [ 53 ].…”

Section: Bronchial Artery Embolizationmentioning

confidence: 99%

The Management of Chronic Pulmonary Aspergillosis: The UK National Aspergillosis Centre Approach

Maghrabi

Denning

2017

Curr Fungal Infect Rep

View full text Add to dashboard Cite

Purpose of ReviewChronic pulmonary aspergillosis (CPA) is a serious long-term fungal disease of the lung with a worldwide prevalence. Treatment of CPA is not straightforward given the often-multiple associated co-morbidities, complex clinical picture, drug interactions, toxicities and intolerances.Recent FindingsFirst line treatment is oral itraconazole or voriconazole. In the event of intolerance or toxicity, patients may be swapped from itraconazole to voriconazole or vice versa. In the event of resistance or further intolerance, third line treatment with posaconazole could be initiated. In those with pan-azole resistance, short-term courses of intravenous liposomal amphotericin B or micafungin are fourth line therapy, keeping in mind the nephrotoxic effects of amphotericin B.SummaryThe available evidence for current treatments in CPA is limited and based mostly on retrospective cohort studies. There is a real need to raise awareness of this devastating disease to enable early treatment as well as prospective drug trials and studies to identify potential patient factors that correlate with progression, severity and overall outcomes in order to target future therapies.

show abstract

Section: Bronchial Artery Embolizationmentioning

confidence: 99%

The Management of Chronic Pulmonary Aspergillosis: The UK National Aspergillosis Centre Approach

Maghrabi

Denning

2017

Curr Fungal Infect Rep

View full text Add to dashboard Cite

show abstract

“…Mild hemoptysis is known to be easily subsided when underlying disease is treated . On the other hand, in moderate hemoptysis, the most critical aspect is the difficulty maintaining an acceptable level of interpersonal relationships and the psychological implications of this call for an effective therapeutic solution . And moderate hemoptysis usually should be distinguished by quantifying daily bleeding amount, and flexible bronchoscopy (FB) is recommended when hemoptysis persists during treatment of underlying disease .…”

Section: Introductionmentioning

confidence: 99%

Moderate hemoptysis: recurrent hemoptysis and mortality according to bronchial artery embolization

Lee

Kim

Yong

et al. 2014

Clinical Respiratory J

View full text Add to dashboard Cite

show abstract

“…In our study, success achieved in 90.4% of our patients. The last two retrospective studies have reported 96% success rate in the control of hemoptysis after BAE [11,12].…”

Section: Discussionmentioning

confidence: 99%

Bronchial Artery Embolization Due to Hemoptysis; Is it really effective?

Güldaval¹

2020

Erciyes Med J

View full text Add to dashboard Cite

Bronchial and nonbronchial systemic artery embolization in managing haemoptysis: 31 years of experience

Abstract: BAE and NBAE are effective and safe for acute treatment of haemoptysis, with low recurrence and complication rates. Interventional radiologist experience is crucial to the successful haemoptysis control and preventing complications.

Cited by 21 publications

References 28 publications

The Management of Chronic Pulmonary Aspergillosis: The UK National Aspergillosis Centre Approach

The Management of Chronic Pulmonary Aspergillosis: The UK National Aspergillosis Centre Approach

Moderate hemoptysis: recurrent hemoptysis and mortality according to bronchial artery embolization

Bronchial Artery Embolization Due to Hemoptysis; Is it really effective?

Contact Info

Product

Resources

About